Implications of continued response after autologous stem cell transplantation for multiple myeloma

Patients undergoing autologous stem cell transplantation (ASCT) for multiple myeloma (MM) undergo disease assessment approximately 100 days later. Some patients continue to have a decline in their serum or urine monoclonal protein after day 100 in the absence of additional therapy. We evaluated 430...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Gonsalves, Wilson I., Gertz, Morie A., Dispenzieri, Angela, Lacy, Martha Q., Lin, Yi, Singh, Preet P., Gupta, Vinay, Hayman, Suzanne R., Buadi, Francis K., Dingli, David, Kapoor, Prashant, McCurdy, Arleigh R., Kumar, Shaji K.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2013
Témata:
Lymphoid Neoplasia
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3765057/
https://ncbi.nlm.nih.gov/pubmed/23863899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-03-492678
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky